CVR 44557703Kaolinvej 5Research and experimental development on natural sciences and engineering · NACE 7210Est. 2024— employees
Revenue 2024
DKK -32K
EBITDA margin
887.2%
Equity ratio
79.2%
Financial strength
Net profit 2024
DKK -286K
EBITDA — year on yearDKK millionsKey figuresAnnual report 2024
Revenue
DKK -32K
—
EBITDA
DKK -285K
—
Net profit
DKK -286K
—
Total assets
DKK 77K
—
Equity
DKK 61K
—
Employees
—
—
Company information
Legal name
Geysir Therapeutics ApS
CVR number
44557703
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
2. januar 2024
Share capital
DKK 40.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen i forening.
Company purpose
Selskabets formål er at drive virksomhed med forskning, udvikling, kommercialisering, handel og fabrikation af lægemidler og dermed beslægtet virksomhed.
Contact
Address
Kaolinvej 5
Email
info@geysirtherapeutics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.